You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Very little has been published on optimization of pharmaceutical portfolios. Moreover, most of published literature is coming from the commercial side, where probability of technical success (PoS) is treated as fixed, and not as a consequence of development strategy or design. In this book there is a strong focus on impact of study design on PoS and ultimately on the value of portfolio. Design options that are discussed in different chapters are dose-selection strategies, adaptive design and enrichment. Some development strategies that are discussed are indication sequencing, optimal number of programs and optimal decision criteria. This book includes chapters written by authors with very br...
This book provides a broad overview of rare disease drug development. It offers unique insights from various perspectives, including third-party capital providers, caregivers, patient advocacy groups, drug development professionals, marketing and commercial experts, and patients. A unique reference, the book begins with narratives on the many challenges faced by rare disease patient and their caregivers. Subsequent chapters underscore the critical, multidimensional role of patient advocacy groups and the novel approaches to related clinical trials, investment decisions, and the optimization of rare disease registries. The book addresses various rare disease drug development processes by disc...
This edited volume is a definitive text on adaptive clinical trial designs from creation and customization to utilization. As this book covers the full spectrum of topics involved in the adaptive designs arena, it will serve as a valuable reference for researchers working in industry, government and academia. The target audience is anyone involved in the planning and execution of clinical trials, in particular, statisticians, clinicians, pharmacometricians, clinical operation specialists, drug supply managers, and infrastructure providers. In spite of the increased efficiency of adaptive trials in saving costs and time, ultimately getting drugs to patients sooner, their adoption in clinical ...
Platform trials test multiple therapies in one indication, one therapy for multiple indications, or both. These novel clinical trial designs can dramatically increase the cost-effectiveness of drug development, leading to life-altering medicines for people suffering from serious illnesses, possibly at lower cost. Currently, the cost of drug development is unsustainable. Furthermore, there are particular problems in rare diseases and small biomarker defined subsets in oncology, where the required sample sizes for traditional clinical trial designs may not be feasible. The editors recruited the key innovators in this domain. The 20 articles discuss trial designs from perspectives as diverse as...
Includes entries for maps and atlases.
Panenka's pearl of a penalty in Belgrade, van Basten's volley of a lifetime in Munich, Gazza's agonising near-miss at Wembley: over its six decades, the UEFA European Championship has thrown up many of the most memorable stories in football lore. Now it gets the history it deserves. Euro Summits is the first full retelling of the tournament, from its tentative beginnings in the late 1950s to its elephantine expansion in the mid-2010s. Taking in the USSR's early success, the grim violence of 1968, France's cavalier feats on home soil in 1984, the sensational triumphs of no-hopers Denmark and Greece, Spain's modern-day dominance, all the way up to Portugal's shock victory in 2016, it's a panoramic portrait of an event that captures a whole continent's imagination every four years. Dramatic, detailed and teeming with compelling personalities like Michel Platini, Guenter Netzer, Hristo Stoichkov, Zinedine Zidane, Wayne Rooney and Cristiano Ronaldo, this is the complete story of a footballing event second only to the World Cup.